Advances in radiotherapy for lung cancer

Article Properties
Cite
Zemanová, Milada. “Advances in Radiotherapy for Lung Cancer”. Onkologie, vol. 12, no. 4, 2018, pp. 155-60, https://doi.org/10.36290/xon.2018.029.
Zemanová, M. (2018). Advances in radiotherapy for lung cancer. Onkologie, 12(4), 155-160. https://doi.org/10.36290/xon.2018.029
Zemanová, Milada. “Advances in Radiotherapy for Lung Cancer”. Onkologie 12, no. 4 (2018): 155-60. https://doi.org/10.36290/xon.2018.029.
Zemanová M. Advances in radiotherapy for lung cancer. Onkologie. 2018;12(4):155-60.
Refrences
Title Journal Journal Categories Citations Publication Date
PORT Meta-analysis Trialists Group. Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials 1998
Geographic differences in the combined-modality treatment of stage III unresectable non-small cell lung cancer: Results from a global phase III trial of tecemotide (L-BLP25) 2013
A Randomized trial of SABR (54Gy/3fx or 48Gy/4fx) vs Conventional Radiotherapy (66Gy/33fx or 50Gy/20fy) for Inoperable Stage I NSCLC: TROG 09.02 (CHISEL) 2017
2014
10.1200/JCO.2005.04.6110
Citations
Title Journal Journal Categories Citations Publication Date
Palliative Radiation Therapy in Symptom Management of Advanced Cancer Onkologie 1 2021
Managing adverse effects of radiotherapy Onkologie 2 2020
Citations Analysis
The first research to cite this article was titled Managing adverse effects of radiotherapy and was published in 2020. The most recent citation comes from a 2021 study titled Palliative Radiation Therapy in Symptom Management of Advanced Cancer. This article reached its peak citation in 2021, with 1 citations. It has been cited in 1 different journals. Among related journals, the Onkologie cited this research the most, with 2 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year